CPSCJuly 6, 2018consumer

Sandoz and Novartis Recall Prescription Drug Blister Packages Due to Failure to Meet Child-Resistant Closure Requirements

Official recall recorded by the U.S. Consumer Product Safety Commission.

The hazard

The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.

What to do

Consumers should immediately secure the blister cards to keep them out of the sight and reach of children and contact Novartis or Sandoz for further instructions. Novartis and Sandoz advise that consumers should continue to use the medication as directed once the blister packages are secured.

Brands named

blisterblister packagessandozsandoz and

UPCs

0781139113100078113921310007811393131000781139613100078113971310007811764131000781176613100078115561310007811695131000781168133307811046131000781104713100
Read the official CPSC notice →

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →